QSS
MRNS

Quantitative Systematic Strategies’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Quantitative Systematic Strategies’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-11,994
Closed -$138K – 687
2018
Q4 		$138K Buy
+11,994
New +$243K 0.03% 580

Other funds holding MRNS

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

Quantitative Systematic Strategies's MRNS Position: Q1 2019 in Review

Quantitative Systematic Strategies sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2019, closing a stake of 11,994 shares — an estimated $138K sold.

Quantitative Systematic Strategies first reported a position in MRNS in Q4 2018 and held it in 1 quarter. The position peaked at $138K in Q4 2018. 81 funds tracked by Wall St. Rank hold MRNS as of Q1 2019.

  • Quantitative Systematic Strategies reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2019 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 11,994 Marinus Pharmaceuticals, Inc shares in Q1 2019, an estimated $138K.
  • Quantitative Systematic Strategies first reported a position in Marinus Pharmaceuticals, Inc in Q4 2018 and held it in 1 quarter.
  • Quantitative Systematic Strategies's Marinus Pharmaceuticals, Inc position peaked at $138K in Q4 2018.
  • 81 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2019.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2019, filed 15 Apr 2019.